| |
|
|
|
|
|
|
|||
|
Blood, 15 January 2007, Vol. 109, No. 2, pp. 756-762. Prepublished online as a Blood First Edition Paper on August 31, 2006; DOI 10.1182/blood-2006-01-011007.
Submitted January 19, 2006
NHLBI, NIH, Bethesda, MD, USA * Corresponding author; email: ygyaozh{at}yahoo.com.
A high frequency of mtDNA somatic mutation has been observed in many tumors as well as in aging tissues. In this study, we analyzed mtDNA control region sequence variation in 3534 single normal cells and individual blasts from 18 leukemia patients and 10 healthy donors, to address the mutation process in leukemic cells. We found significant differences in mtDNA sequence, as represented by the number of haplotypes and the mean number of cells with each nonaggregate haplotype in a population of cells, in patients compared to controls. Patients with similar clinical leukemia types, particularly AML, did not show a uniform pattern of sequence variation in single blasts. Some relapsed patients presented a complex shift of major haplotypes in single cells. Four patients showed high frequencies of cells containing mutations 189, 260, 16150, and 16488, respectively, as a result of clonal expansion, and could be considered as potential markers for their respective disease progression. To our knowledge, this is the first large-scale study of mtDNA variation in single malignant cells. Our results suggest that the somatic mutation process in leukemia is complex, leading to diverse levels of genetic alterations due to either intrinsic aspects of leukemia pathophysiology and/or chemotherapy effects.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||